Related Experiment Video
Updated: Jun 13, 2026

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
Clinical and neuroimaging findings of Cree leukodystrophy: a retrospective case series
S Harder1, A Gourgaris, E Frangou
1Department of Radiology, Loma Linda University Medical Center, Loma Linda, CA, USA.
Insights
Cerebral leukodystrophy (CLD) in infants presents with characteristic neuroimaging findings, including white matter and globus pallidus abnormalities. Genetic testing revealed mutations in the eIF2B5 gene in some cases.
Area of Science:
- Pediatric Neurology
- Neuroimaging
- Genetic Disorders
Background:
- Cerebral leukodystrophy (CLD) is a fatal, rapidly progressive neurodegenerative disorder in infants.
- This study focuses on the clinical and neuroimaging characteristics of CLD.
Purpose of the Study:
- To describe the clinical and neuroimaging findings in five infants diagnosed with CLD.
- To highlight the diagnostic utility of neuroimaging in CLD.
Main Methods:
- Retrospective review of medical records for infants with CLD over 11 years.
- Analysis of clinical, demographic, postmortem, genetic, CT, and MR imaging data.
- Magnetic Resonance Spectroscopy (MRS) was utilized.
Main Results:
- Five Cree infants diagnosed with CLD exhibited specific CT and MR imaging patterns.
- Imaging showed white matter and globus pallidus hypoattenuation/T2 hyperintensity, with thalamic and substantia nigra involvement.
- MRS revealed decreased NAA, elevated choline, and lactate; genetic testing identified eIF2B5 gene mutations in two infants.
Conclusions:
- Neuroimaging is crucial for diagnosing CLD, showing characteristic white matter, globus pallidus, thalamic, and substantia nigra abnormalities.
- MRS findings suggest parenchymal destruction and anaerobic metabolism.
- Clinical suspicion of VWM in Native American infants warrants consideration of CLD, imaging, and genetic testing.
Background And Purpose:
CLD is a rapidly progressive and invariably fatal neurodegenerative disorder. We describe clinical and neuroimaging findings in 5 infants with CLD.
Materials And Methods:
Retrospective review of medical records of infants with CLD from the past 11 years at our institution was performed. Relevant clinical and demographic data were recorded. Specific attention was directed toward postmortem examination findings and genetic testing. CT and MR imaging results were reviewed.
Results:
Five Cree infants were diagnosed with CLD. CT demonstrated bilateral symmetric hypoattenuation of the white matter and globus pallidus. MR imaging demonstrated corresponding T2 hyperintensity in these regions and abnormal signal intensity in the thalami and substantia nigra. Symmetric restricted diffusion in the deep white matter was seen. MRS demonstrated decreased NAA, elevated choline, and the presence of lactate. Postmortem examination in 1 infant showed corresponding poor myelination in the brain stem, cerebellum, deep gray structures, and the cerebral hemispheres. Genetic testing in 2 infants revealed homozygous mutations in the eIF2B5 gene.
Conclusions:
Neuroimaging in CLD is striking and is an important tool in diagnosing CLD. Extensive white matter involvement as well as involvement of the globus pallidus and patchy involvement of the thalami and substantia nigra are characteristic. MRS findings are compatible with destruction of normal brain parenchyma with evidence of anaerobic metabolism in the regions of demyelination. Clinical suspicion of VWM in a Native American infant from this region should prompt the consideration of CLD with appropriate imaging work-up and genetic testing.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Cerebral Edema ll: Pathophysiology
Cryptococcal Meningitis
Multiple Sclerosis l: Introduction

